BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger

  April 7, 2025

   · 

  14 min read
• Press Releases

  ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 4, 2025

  April 7, 2025

   · 

  4 min read
• Press Releases

  Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

  April 7, 2025

   · 

  10 min read
• Press Releases

  Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders

  April 7, 2025

   · 

  10 min read
• Press Releases

  TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to significantly reduce both the signs and symptoms and the progression of structural damage in adults living with active psoriatic arthritis

  April 7, 2025

   · 

  13 min read
• Press Releases

  Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025

  April 7, 2025

   · 

  5 min read
• Press Releases

  Sarepta Therapeutics Provides Update on ELEVIDYS

  April 7, 2025

   · 

  8 min read
• Press Releases

  Edesa Biotech Announces Chief Financial Officer Transition

  April 7, 2025

   · 

  4 min read
• Press Releases

  UPSHER-SMITH TO SHOWCASE RARE DISEASE PORTFOLIO AT 2025 AAN ANNUAL MEETING

  April 7, 2025

   · 

  21 min read
• Press Releases

  Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 4, 2025

  April 7, 2025

   · 

  1 min read